AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
PHASE-I PHARMACOLOGICAL STUDY OF INTRAARTERIALLY INFUSED FOTEMUSTINE FOR COLORECTAL LIVER METASTASES
Authors: HARTMANN JT SCHMOLL E BOKEMEYER C FETY R LUCAS C GIROUX B SCHMOLL HJ
Citation: Jt. Hartmann et al., PHASE-I PHARMACOLOGICAL STUDY OF INTRAARTERIALLY INFUSED FOTEMUSTINE FOR COLORECTAL LIVER METASTASES, European journal of cancer, 34(1), 1998, pp. 87-91
PHASE-II STUDY OF CONTINUOUS 120 H INFUSION OF MITOMYCIN-C AS SALVAGECHEMOTHERAPY IN PATIENTS WITH PROGRESSIVE OR RAPIDLY RECURRENT COLORECTAL-CANCER
Authors: HARTMANN JT HARSTRICK A DAIKELER T KOLLMANNSBERGER C MULLER C SEEBER S KANZ L BOKEMEYER C
Citation: Jt. Hartmann et al., PHASE-II STUDY OF CONTINUOUS 120 H INFUSION OF MITOMYCIN-C AS SALVAGECHEMOTHERAPY IN PATIENTS WITH PROGRESSIVE OR RAPIDLY RECURRENT COLORECTAL-CANCER, Anti-cancer drugs, 9(5), 1998, pp. 427-431
A PHASE-II TRIAL OF PACLITAXEL, CISPLATIN, AND WEEKLY 24 H INFUSION OF 5-FLUOROURACIL (5-FU) FOLINIC ACID (FA) IN PATIENTS (PTS) WITH ADVANCED GASTRIC-CANCER/
Authors: KOLLMANNSBERGER C QUIETZCH D CLEMENS M LAMPE C LINGENFELSER T HARTMANN JT KANZ L BOKEMEYER C
Citation: C. Kollmannsberger et al., A PHASE-II TRIAL OF PACLITAXEL, CISPLATIN, AND WEEKLY 24 H INFUSION OF 5-FLUOROURACIL (5-FU) FOLINIC ACID (FA) IN PATIENTS (PTS) WITH ADVANCED GASTRIC-CANCER/, Annals of oncology, 9, 1998, pp. 229-229
FDG-PET FOR THE EVALUATION OF HIGH-DOSE CHEMOTHERAPY (HD-CTX) IN PATIENTS WITH METASTATIC GERM-CELL TUMORS (GCT)
Authors: BOKEMEYER G KOLLMANNSBERGER O SOKLER W DOHMEN BM OECHSLE K HARTMANN JT PFANNENBERG AC BARES R KANZ L
Citation: G. Bokemeyer et al., FDG-PET FOR THE EVALUATION OF HIGH-DOSE CHEMOTHERAPY (HD-CTX) IN PATIENTS WITH METASTATIC GERM-CELL TUMORS (GCT), Annals of oncology, 9, 1998, pp. 267-267
EXTRAGONADAL GERM-CELL TUMORS (EGGCT) AND HEMATOLOGIC DISORDERS - INCIDENCE AND OUTCOME FROM AN INTERNATIONAL DATABASE
Authors: HARTMANN JT NICHOLS CR DROZ JP HORWICH A GERL A FOSSA SD BEYER J PONT J SCHMOLL HJ BOKEMEYER C
Citation: Jt. Hartmann et al., EXTRAGONADAL GERM-CELL TUMORS (EGGCT) AND HEMATOLOGIC DISORDERS - INCIDENCE AND OUTCOME FROM AN INTERNATIONAL DATABASE, Annals of oncology, 9, 1998, pp. 268-268
SECONDARY LEUKEMIA FOLLOWING HIGH CUMULATIVE DOSES OF ETOPOSIDE IN PATIENTS TREATED FOR ADVANCED GERM-CELL TUMORS
Authors: KOLLMANNSBERGER C BOYER J DROZ JP HARSTRICK A HARTMANN JT BIRON P FLECHON A SCHOFFSKI P KUCZYK M SCHMOLL HJ KANZ L BOKEMEYER C
Citation: C. Kollmannsberger et al., SECONDARY LEUKEMIA FOLLOWING HIGH CUMULATIVE DOSES OF ETOPOSIDE IN PATIENTS TREATED FOR ADVANCED GERM-CELL TUMORS, Journal of clinical oncology, 16(10), 1998, pp. 3386-3391
RECENT STRATEGIES FOR THE USE OF PACLITAXEL IN THE TREATMENT OF UROLOGICAL MALIGNANCIES
Authors: BOKEMEYER C HARTMANN JT KUCZYK MA TRUSS MC KOLLMANNSBERGER C BEYER J JONAS U KANZ L
Citation: C. Bokemeyer et al., RECENT STRATEGIES FOR THE USE OF PACLITAXEL IN THE TREATMENT OF UROLOGICAL MALIGNANCIES, World journal of urology, 16(2), 1998, pp. 155-162
REGISTER STUDY FOR THE TREATMENT OF BRAIN METASTASES OF MALIGNANT TESTICULAR-TUMORS
Authors: HARTMANN JT ALBERS P CLEMM C SOUCHON R WEISSBACH L BAMBERG M BOKEMEYER C
Citation: Jt. Hartmann et al., REGISTER STUDY FOR THE TREATMENT OF BRAIN METASTASES OF MALIGNANT TESTICULAR-TUMORS, Onkologie, 21(3), 1998, pp. 262-263
FIRST-LINE HIGH-DOSE CHEMOTHERAPY FOR POOR-RISK METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS
Authors: BOKEMEYER C HARSTRICK A BEYER J METZNER B RUTHER U HARTMANN JT HOLSTEIN K DERIGS HG DEWIT R CASPER J SCHOFFSKI P KUHRER I ILLIGER HJ KEMPF B REICHLE A FOLLER A HOSSFELD DK FISCHER JT BERDEL W GERHARTZ H KIRCHNER H PFLUGER K OSTERMANN H KANZ L SCHMOLL HJ
Citation: C. Bokemeyer et al., FIRST-LINE HIGH-DOSE CHEMOTHERAPY FOR POOR-RISK METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Onkologie, 21, 1998, pp. 23-25
PROGNOSTIC VALUE OF INTRACAVAL NEOPLASTIC EXTENSION FOR PATIENTS WITHRENAL-CELL CANCER
Authors: KUCZYK MA KOHN G HOFNER K MACHTENS S BOKEMEYER C STIEF CG TRUSS MC SCHAFERS HJ HARTMANN JT JONAS U
Citation: Ma. Kuczyk et al., PROGNOSTIC VALUE OF INTRACAVAL NEOPLASTIC EXTENSION FOR PATIENTS WITHRENAL-CELL CANCER, Der Urologe, 37(3), 1998, pp. 299-305
REGISTER STUDY OF PATIENTS WITH CNS METASTASES FROM TESTICULAR GERM-CELL CANCER
Authors: HARTMANN JT ALBERS P CLEMM C SOUCHON R WEISSBACH L BAMBERG M BOKEMEYER C
Citation: Jt. Hartmann et al., REGISTER STUDY OF PATIENTS WITH CNS METASTASES FROM TESTICULAR GERM-CELL CANCER, Strahlentherapie und Onkologie, 174(6), 1998, pp. 339-339
RISK OF SECONDARY MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME FOLLOWING STANDARD-DOSE CHEMOTHERAPY OR HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL SUPPORT IN PATIENTS WITH POTENTIALLY CURABLE MALIGNANCIES
Authors: KOLLMANNSBERGER C HARTMANN JT KANZ L BOKEMEYER C
Citation: C. Kollmannsberger et al., RISK OF SECONDARY MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME FOLLOWING STANDARD-DOSE CHEMOTHERAPY OR HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL SUPPORT IN PATIENTS WITH POTENTIALLY CURABLE MALIGNANCIES, Journal of cancer research and clinical oncology, 124(3-4), 1998, pp. 207-214
THE USE OF DOSE-INTENSIFIED CHEMOTHERAPY IN THE TREATMENT OF METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS
Authors: BOKEMEYER C HARSTRICK A BEYER J METZNER B RUTHER U HARTMANN JT HOLSTEIN K DERIGS HG DEWIT R CASPER J SCHOFFSKI P KUHRER I ILLIGER HJ KEMPF B REICHLE A FOLLER A HOSSFELD DK FISCHER JT BERDEL WE GERHARTZ HH KIRCHNER H PFLUGER KH OSTERMANN H KANZ L SCHMOLL HJ
Citation: C. Bokemeyer et al., THE USE OF DOSE-INTENSIFIED CHEMOTHERAPY IN THE TREATMENT OF METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Seminars in oncology, 25(2), 1998, pp. 24-32
IS CONTINUOUS 24-HOUR INFUSION OF 5-FLUOROURACIL PLUS HIGH-DOSE FOLINIC ACID EFFECTIVE IN PATIENTS WITH PROGRESSIVE OR RECURRENT COLORECTAL-CANCER - A PHASE-II STUDY
Authors: HARTMANN JT KOHNE CH SCHMOLL HJ DAIKELER T KANZ L BOKEMEYER C
Citation: Jt. Hartmann et al., IS CONTINUOUS 24-HOUR INFUSION OF 5-FLUOROURACIL PLUS HIGH-DOSE FOLINIC ACID EFFECTIVE IN PATIENTS WITH PROGRESSIVE OR RECURRENT COLORECTAL-CANCER - A PHASE-II STUDY, Oncology, 55(4), 1998, pp. 320-325
ANALYSIS OF RISK-FACTORS FOR CISPLATIN-INDUCED OTOTOXICITY IN PATIENTS WITH TESTICULAR CANCER
Authors: BOKEMEYER C BERGER CC HARTMANN JT KOLLMANNSBERGER C SCHMOLL HJ KUCZYK MA KANZ L
Citation: C. Bokemeyer et al., ANALYSIS OF RISK-FACTORS FOR CISPLATIN-INDUCED OTOTOXICITY IN PATIENTS WITH TESTICULAR CANCER, British Journal of Cancer, 77(8), 1998, pp. 1355-1362
THE INFLUENCE OF GEMCITABINE ON THE CD4 CD8 RATIO IN PATIENTS WITH SOLID TUMORS/
Authors: DAIKELER T MAAS K WEISS B HARTMANN JT KNOBLOCH A ARNING M KANZ L BOKEMEYER C
Citation: T. Daikeler et al., THE INFLUENCE OF GEMCITABINE ON THE CD4 CD8 RATIO IN PATIENTS WITH SOLID TUMORS/, Oncology Reports, 4(3), 1997, pp. 561-564
HEPATIC ARTERIAL INFUSION OF THE NITROSOUREA DERIVATE FOTEMUSTINE FORTHE TREATMENT OF LIVER METASTASES FROM COLORECTAL-CARCINOMA
Authors: HARTMANN JT SCHMOLL E BOKEMEYER C FETY R LUCAS C DAGAY L SCHMOLL HJ
Citation: Jt. Hartmann et al., HEPATIC ARTERIAL INFUSION OF THE NITROSOUREA DERIVATE FOTEMUSTINE FORTHE TREATMENT OF LIVER METASTASES FROM COLORECTAL-CARCINOMA, Oncology Reports, 4(1), 1997, pp. 167-172
AMIFOSTINE PROTECTS AGAINST ACUTE CISPLATIN IFOSFAMIDE-INDUCED KIDNEYDAMAGE ASSESSED BY MEASUREMENT OF GLOMERULAR AND TUBULAR ENZYMES/
Authors: BOKEMEYER C HARTMANN JT FELS L KNOP S STOLTE H KANZ L
Citation: C. Bokemeyer et al., AMIFOSTINE PROTECTS AGAINST ACUTE CISPLATIN IFOSFAMIDE-INDUCED KIDNEYDAMAGE ASSESSED BY MEASUREMENT OF GLOMERULAR AND TUBULAR ENZYMES/, European journal of cancer, 33, 1997, pp. 56-56
LONG-TERM EFFECTS OF TESTICULAR CANCER-TREATMENT ON SEXUAL FUNCTIONING
Authors: HARTMANN JT ALBRECHT C KANZ L BOKEMEYER C
Citation: Jt. Hartmann et al., LONG-TERM EFFECTS OF TESTICULAR CANCER-TREATMENT ON SEXUAL FUNCTIONING, European journal of cancer, 33, 1997, pp. 157-157
PHASE-II STUDY OF 24 HOURS-INFUSION OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN PATIENTS WITH PROGRESSIVE OR RECURRENT COLORECTAL-CANCER (CRC)
Authors: HARTMANN JT KOHNE CH SCHMOLL HJ KOLLMANNSBERGER C KANZ L BOKEMEYER C
Citation: Jt. Hartmann et al., PHASE-II STUDY OF 24 HOURS-INFUSION OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN PATIENTS WITH PROGRESSIVE OR RECURRENT COLORECTAL-CANCER (CRC), European journal of cancer, 33, 1997, pp. 759-759
CONTINUOUS 120 HOURS-INFUSION OF MITOMYCIN-C (MMC) AS SALVAGE TREATMENT IN PROGRESSIVE OR RAPIDLY RECURRENT GASTRIC-CANCER
Authors: HARTMANN JT CANDELARIA M JACKH G SCHMOLL HJ HARSTRICK A KANZ L BOKEMEYER C
Citation: Jt. Hartmann et al., CONTINUOUS 120 HOURS-INFUSION OF MITOMYCIN-C (MMC) AS SALVAGE TREATMENT IN PROGRESSIVE OR RAPIDLY RECURRENT GASTRIC-CANCER, European journal of cancer, 33, 1997, pp. 1257-1257
COMPARISON OF HISTOLOGICAL RESULTS FROM THE RESECTION OF RESIDUAL MASSES AT DIFFERENT SITES AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS
Authors: HARTMANN JT CANDELARIA M KUCZYK MA SCHMOLL HJ BOKEMEYER C
Citation: Jt. Hartmann et al., COMPARISON OF HISTOLOGICAL RESULTS FROM THE RESECTION OF RESIDUAL MASSES AT DIFFERENT SITES AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS, European journal of cancer, 33(6), 1997, pp. 843-847
WEEKLY SHORT INFUSIONS OF GEMCITABINE ARE NOT ASSOCIATED WITH SUPPRESSION OF LYMPHATIC ACTIVITY IN PATIENTS WITH SOLID TUMORS
Authors: DAIKELER T MAAS K HARTMANN JT KANZ L BOKEMEYER C
Citation: T. Daikeler et al., WEEKLY SHORT INFUSIONS OF GEMCITABINE ARE NOT ASSOCIATED WITH SUPPRESSION OF LYMPHATIC ACTIVITY IN PATIENTS WITH SOLID TUMORS, Anti-cancer drugs, 8(6), 1997, pp. 643-644
A PHASE-II TRIAL OF PACLITAXEL AND WEEKLY 24 H INFUSION OF 5-FLUOROURACIL FOLINIC ACID IN PATIENTS WITH ADVANCED GASTRIC-CANCER
Authors: BOKEMEYER C LAMPE CS CLEMENS MR HARTMANN JT QUIETZSCH D FORKMANN L KOLLMANNSBERGER C KANZ L
Citation: C. Bokemeyer et al., A PHASE-II TRIAL OF PACLITAXEL AND WEEKLY 24 H INFUSION OF 5-FLUOROURACIL FOLINIC ACID IN PATIENTS WITH ADVANCED GASTRIC-CANCER, Anti-cancer drugs, 8(4), 1997, pp. 396-399
POSTCHEMOTHERAPY RESECTIONS OF RESIDUAL MASSES FROM METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS
Authors: HARTMANN JT SCHMOLL HJ KUCZYK MA CANDELARIA M BOKEMEYER C
Citation: Jt. Hartmann et al., POSTCHEMOTHERAPY RESECTIONS OF RESIDUAL MASSES FROM METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Annals of oncology, 8(6), 1997, pp. 531-538
Risultati: 1-25 | 26-34